Hironobu Ohmatsu Selected Research

Lymphoma (Lymphomas)

4/2013

Meta-analysis of epoetin beta and darbepoetin alfa treatment for chemotherapy-induced anemia and mortality: Individual patient data from Japanese randomized, placebo-controlled trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hironobu Ohmatsu Research Topics

Disease

28	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 02/2002
26	Neoplasms (Cancer) 01/2017 - 01/2002
10	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2016 - 07/2008
5	Interstitial Lung Diseases (Interstitial Lung Disease) 07/2015 - 09/2010
3	Adenocarcinoma of Lung 01/2016 - 10/2013
3	Lung Neoplasms (Lung Cancer) 07/2015 - 02/2004
3	Thymoma (Thymic Carcinoma) 07/2015 - 09/2003
3	Neoplasm Metastasis (Metastasis) 09/2012 - 05/2006
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017 - 06/2012
2	Adenocarcinoma 01/2016 - 06/2012
2	Febrile Neutropenia 10/2015 - 03/2014
2	Pleural Effusion (Pleural Effusions) 04/2011 - 07/2008
2	Cushing Syndrome 01/2011 - 09/2003
2	Neutropenia 07/2007 - 07/2004
2	Phlebitis 03/2007 - 04/2004
1	Malignant Mesothelioma 01/2017
1	Ascites 01/2017
1	Disease Progression 01/2017
1	Tracheal Stenosis 01/2016
1	Anemia 04/2013
1	Lymphoma (Lymphomas) 04/2013
1	Lymphatic Metastasis 01/2013
1	Carcinoma (Carcinomatosis) 03/2012
1	Hemorrhage 01/2012
1	Pericardial Effusion 04/2011
1	Respiratory Insufficiency (Respiratory Failure) 09/2010
1	Radiation Pneumonitis 06/2008
1	Fever (Fevers) 02/2004

Drug/Important Bio-Agent (IBA)

9	Cisplatin (Platino)FDA LinkGeneric 04/2016 - 02/2002
6	PlatinumIBA 01/2017 - 07/2003
6	Gefitinib (Iressa)FDA Link 10/2016 - 01/2006
6	Tyrosine Kinase InhibitorsIBA 01/2016 - 12/2008
6	ErbB Receptors (EGF Receptor)IBA 01/2016 - 01/2006
6	Docetaxel (Taxotere)FDA Link 07/2015 - 02/2002
5	Vinorelbine (Navelbine)FDA LinkGeneric 03/2015 - 04/2004
4	Cadherins (E-Cadherin)IBA 01/2016 - 06/2012
4	Carboplatin (JM8)FDA LinkGeneric 03/2014 - 10/2007
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2016 - 01/2016
3	amrubicinIBA 10/2015 - 09/2010
3	Irinotecan (Camptosar)FDA LinkGeneric 09/2014 - 01/2002
3	Etoposide (VP 16)FDA LinkGeneric 03/2014 - 09/2003
2	ezrinIBA 01/2016 - 07/2015
2	Proteins (Proteins, Gene)FDA Link 07/2015 - 12/2008
2	DNA (Deoxyribonucleic Acid)IBA 09/2014 - 12/2008
2	AnthracyclinesIBA 03/2014 - 09/2010
2	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2011 - 09/2003
2	Gemcitabine FDA Link 09/2009 - 07/2003
2	Irritants (Vesicants)IBA 03/2007 - 04/2004
1	S-1 plus cisplatinIBA 01/2018
1	Growth Factor ReceptorsIBA 01/2017
1	Bevacizumab (Avastin)FDA Link 01/2017
1	Monoclonal AntibodiesIBA 10/2016
1	emibetuzumabIBA 10/2016
1	Pemetrexed (MTA)FDA Link 04/2016
1	KalininIBA 01/2016
1	AfatinibIBA 01/2016
1	GemininIBA 04/2015
1	Therapeutic UsesIBA 02/2015
1	Biomarkers (Surrogate Marker)IBA 12/2013
1	Aldehyde Dehydrogenase 1 FamilyIBA 12/2013
1	130-nm albumin-bound paclitaxelIBA 07/2013
1	Darbepoetin alfa (Aranesp)FDA Link 04/2013
1	epoetin betaIBA 04/2013
1	Caveolin 1IBA 01/2013
1	Zoledronic Acid (Zometa)FDA Link 09/2012
1	CateninsIBA 06/2012
1	Differentiation AntigensIBA 06/2012
1	Mitotane (Lysodren)FDA Link 01/2011
1	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2010
1	ParaffinIBA 12/2008
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2007
1	GlucuronidesIBA 07/2007
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2004
1	Ciprofloxacin (Cipro)FDA LinkGeneric 02/2004
1	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 02/2004
1	Ceftazidime (Fortum)FDA LinkGeneric 02/2004
1	Amoxicillin (Wymox)FDA LinkGeneric 02/2004
1	Vincristine (Oncovin)FDA LinkGeneric 09/2003
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2003
1	Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA 01/2002

Therapy/Procedure

23	Drug Therapy (Chemotherapy) 01/2017 - 07/2003
7	Therapeutics 01/2017 - 07/2008
5	Radiotherapy 01/2018 - 03/2005
4	Combination Drug Therapy (Combination Chemotherapy) 04/2016 - 07/2003
4	Chemoradiotherapy 01/2012 - 06/2008
3	Induction Chemotherapy 01/2017 - 03/2005
2	Aftercare (After-Treatment) 02/2015 - 12/2013
1	Maintenance Chemotherapy 01/2017
1	Palliative Care (Palliative Therapy) 01/2017
1	Proton Therapy 01/2016
1	Neoadjuvant Therapy 12/2013